Park et al., 2012 - Google Patents
Expression of Kisspeptin and its receptor GPR54 in the first trimester trophoblast of women with recurrent pregnancy lossPark et al., 2012
View PDF- Document ID
- 13931125763761995794
- Author
- Park D
- Lee S
- Hong S
- Han A
- Kwak‐Kim J
- Yang K
- Publication year
- Publication venue
- American journal of reproductive immunology
External Links
Snippet
Citation Park D‐W, Lee S‐K, Hong SR, Han A‐R, Kwak‐Kim J, Yang KM. Expression of kisspeptin and its receptor GPR54 in the first trimester trophoblast of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 2012; 67: 132–139 Problem Kisspeptin and its …
- 210000002993 Trophoblasts 0 title abstract description 86
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Park et al. | Expression of Kisspeptin and its receptor GPR54 in the first trimester trophoblast of women with recurrent pregnancy loss | |
Jin et al. | Placental exosomes: A proxy to understand pregnancy complications | |
Kuon et al. | Uterine natural killer cells in patients with idiopathic recurrent miscarriage | |
Binder et al. | Endometrial signals improve embryo outcome: functional role of vascular endothelial growth factor isoforms on embryo development and implantation in mice | |
Griffith et al. | Embryo implantation evolved from an ancestral inflammatory attachment reaction | |
Murray et al. | Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis | |
Hoffmann et al. | Role of EG‐VEGF in human placentation: Physiological and pathological implications | |
Chen et al. | Decreased blood vessel density and endothelial cell subset dynamics during ageing of the endocrine system | |
Qu et al. | Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells | |
Di Simone et al. | Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β2glycoprotein I | |
Chen et al. | Decreased IL‐33 production contributes to trophoblast cell dysfunction in pregnancies with preeclampsia | |
LaMarca et al. | Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases | |
Aghababaei et al. | A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development | |
Siddiqui et al. | Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker | |
JP2013520958A (en) | Method of using AXL as a biomarker for epithelial-mesenchymal transition | |
Mansfield et al. | Pregnancy-associated plasma protein-A expression in human breast cancer | |
Xu et al. | Downregulation of vitamin D receptor and miR‐126‐3p expression contributes to increased endothelial inflammatory response in preeclampsia | |
Radovick et al. | Regulation of pregnancy: Evidence for major roles by the uterine and placental kisspeptin/KISS1R signaling systems | |
Ma et al. | Upregulation of RND3 affects trophoblast proliferation, apoptosis, and migration at the maternal-fetal interface | |
Ohmura et al. | Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss | |
Wu et al. | Nuclear receptor coactivator 6 promotes HTR‐8/SVneo cell invasion and migration by activating NF‐κB‐mediated MMP9 transcription | |
Vilsmaier et al. | The decidual expression of Interleukin‐7 is upregulated in early pregnancy loss | |
Schäfer‐Somi et al. | Kisspeptin‐10 and the G protein‐coupled receptor 54 are differentially expressed in the canine pregnant uterus and trophoblast cells | |
Gajbhiye | Endometriosis and inflammatory immune responses: Indian experience | |
Agostinis et al. | Pre‐eclampsia affects procalcitonin production in placental tissue |